Adelmidrol is the semisynthetic diethanolamide derivative of [[azelaic acid]],<ref name="Cerrato">{{cite journal|last1=Cerrato|first1=Santiago|last2=Brazis|first2=Pilar|last3=della Valle|first3=Maria Federica|last4=Miolo|first4=Alda|last5=Puigdemont|first5=Anna|title=Inhibitory effect of topical Adelmidrol on antigen-induced skin wheal and mast cell behavior in a canine model of allergic dermatitis|journal=BMC Veterinary Research|date=2012|volume=8|issue=1|pages=230|doi=10.1186/1746-6148-8-230|accessdate=2017-01-28}}</ref> and has a symmetrical chemical structure. It classed as an  [[ALIAmide]], and is similar to [[palmitoylethanolamide]], the parent molecule in the ALIAmide class of drugs.<ref name="DeFilippis">{{cite journal|last1=De Filippis|first1=Daniele|last2=D’Amico|first2=Alessandra|last3=Cinelli|first3=Maria Pia|last4=Esposito|first4=Giuseppe|last5=Di Marzo|first5=Vincenzo|last6=Iuvone|first6=Teresa|title=Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats|journal=Journal of Cellular and Molecular Medicine|date=1 July 2009|volume=13|issue=6|pages=1086–1095|doi=10.1111/j.1582-4934.2008.00353.x|accessdate=2017-01-28}}</ref> ALIAmides are group of fatty acid derivatives with cannabimimetic properties,<ref name="Cerrato" /> which have antiinflammatory and analgesic effects and are thought to act by reducing [[mast cell]] activation.<ref name="DeFilippis" />

 
A 4-week topical treatment with adelmidrol 2% emulsion in children affected by mild atopic dermatitis resulted in complete resolution in 80% of cases, with no side effects and no relapses at 8-week follow up.<ref>Pulvirenti N, Nasca MR, Micali G: Topical adelmidrol 2% emulsion, a novel aliamide, in the treatment of mild atopic dermatitis in pediatric subjects: a pilot study. Acta Dermatovenerol Croat 2007, 15:80-83.</ref>
